Legal and Tax Essentials of Star Health “Super Star” (UIN SHAHLIP27049V022627)

This article explains the legal structure, coverage mechanics, GST treatment and income-tax implications of the Star Health “Super Star” individual health insurance policy carrying IRDAI UIN SHAHLIP27049V022627, with focus on assessment years around 2026-27.

It is written for advisers who must read beyond marketing summaries to the filed wording, understand how waiting periods and add-ons actually apply at claim stage, and align premium decisions with GST and Section 80D outcomes.


1. Issue, law, position, action: the UIN and core coverage

1.1 Issue: What does the UIN cover and how is the product positioned in law?

“Super Star” with UIN SHAHLIP27049V022627 is recorded in the insurer’s product list as an individual health insurance policy launched on 26 May 2026. It is described as an indemnity-based health insurance product, available as:

  • Individual cover; and
  • Family-floater cover for proposer, spouse or live-in partner, and up to four dependent children, subject to eligibility and underwriting.

The key feature is indemnity: admissible hospitalisation and specified treatment expenses are paid (cashless or reimbursement) up to:

  • The sum insured; and
  • Applicable internal limits, sublimits, co-pays and deductibles.

It is not a fixed-benefit policy that pays a predetermined lump sum on diagnosis.

1.2 Governing law and regulatory framework

Key authorities and frameworks:

  • IRDAI health insurance regulations and related FAQs:

    • Standardisation of definitions (e.g., “pre-existing disease”, “hospitalisation”, “daycare treatment”, “network provider”, “reasonable and customary charges”).
    • Rules on free-look, renewal, migration/portability, waiting-period continuity and claim repudiation.
  • Insurance contract law:

    • Proposal form, policy wording, schedule and endorsements constitute the binding contract.
    • Duty of disclosure and consequences of misrepresentation or non-disclosure.
  • Star Health product filings with IRDAI:

    • The filed wording, prospectus and customer information sheet linked to UIN SHAHLIP27049V022627 define the final benefit structure.

1.3 Working position for practitioners

  1. UIN as primary identifier

    • For legal analysis and claim disputes, the UIN identifies the precise filed wording.
    • Product names and marketing brochures may change or be reused, but the UIN (here, SHAHLIP27049V022627) ties the contract to a specific set of terms.
  2. Indemnity nature and limits

    • Coverage is constrained by:
      • Sum insured (base and any restored or bonus amounts).
      • Internal limits and cost-controls such as “reasonable and customary charges”.
      • Waiting periods and exclusions.
    • No room-rent cap is indicated in the current FAQ, but this does not mean absolute freedom of choice; room costs remain subject to reasonable and customary charges and medical necessity.
  3. Eligibility and sum insured

    • For entry age above 65, the FAQ mentions a maximum sum insured of ₹50 lakh, subject to underwriting.
    • Family-floater covers multiple insureds but shares the sum insured.

1.4 Immediate action points

For new or renewing clients:

  1. Match all documents to the UIN

    • Confirm that:
      • Proposal form, quotation and schedule mention UIN SHAHLIP27049V022627.
      • Any optional add-ons and benefits appear on the schedule with clear identifiers.
  2. Clarify indemnity scope in writing

    • Obtain and retain:
      • Policy wording (full contract).
      • Prospectus and customer information sheet applicable to the UIN.
    • Highlight to the assessee that benefits are reimbursement/indemnity-based, not fixed payouts.
  3. Check entry conditions and insured relationships

    • Verify that each intended insured fits the relationship and age criteria in the filed wording, especially in live-in partner situations.

2. Waiting periods, optional covers and exclusions

2.1 Issue: How do waiting periods interact, and what is the real scope of cover?

The product specifies three primary waiting categories:

  • Initial waiting: 30 days for illnesses (accidents typically exempt).
  • Specified diseases/procedures: 24 months.
  • Pre-existing diseases (PED): 36 months.

Optional covers can shorten some waiting periods (for example, an option where certain conditions are covered from day 31), and separate options apply for maternity coverage with different waiting variants and sublimits.

Base exclusions cover areas including:

  • Treatment for obesity/weight control.
  • Dietary supplements not part of admissible treatment.
  • Substance abuse treatment.
  • Hazardous or adventure sports.
  • Cosmetic surgery except defined reconstructive indications.
  • Unproven treatments and intentional self-injury.
  • Vaccination, except to the extent expressly included in specific benefits.

2.2 Law and regulatory expectations

  • IRDAI mandates clear disclosure of waiting periods and standard definitions of key terms.
  • The definition of “pre-existing disease” must follow the wording filed and IRDAI’s standardisation.
  • For optional waiting-period reductions and maternity covers, the insurer must file the terms and conditions with IRDAI.

2.3 Position: How to interpret these provisions

  1. Waiting periods are independent constraints

    • The 30-day initial period, the 24-month specified-disease period and the 36‑month PED period apply separately.
    • A claim may satisfy one and still fail another.
      • Example: A procedure after 3 months is beyond the 30-day bar but can still be denied if it falls under a 24-month specified list.
      • Likewise, a PED-related claim after 24 months may still be excluded until 36 months are complete.
  2. Optional waiting-period reductions are targeted

    • An add-on like a “Quick Shield”-style waiting reduction only modifies the particular conditions and waiting intervals listed for that option.
    • It does not compress all waiting periods nor override unrelated exclusions.